NCT00650364View on ClinicalTrials.gov

Fasting Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

August 31, 2002

Study Completion Date

September 30, 2002

Conditions
Healthy
Interventions
DRUG

Midodrine HCl Tablets 5 mg

5mg, single dose fasting

DRUG

ProAmatine® Tablets 5 mg

5mg, single dose fasting

Trial Locations (1)

26505

Kendle International Inc., Morgantown

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY